Archive for August 2013
Ass’n for Molecular Pathology v. Myriad Genetics, Inc., No. 12-398, slip op. (U.S. June 13, 2013)
Caile Morris On June 13, 2013, the United States Supreme Court took a new stance in the patenting of genes in a landmark ruling that may have broad implications for biomedical businesses. In Association for Molecular Pathology v. Myriad Genetics, Inc., the Court ruled that the location and isolation of the DNA sequences were not…
Read More